# HILLEVAX INC (HLVX)

> Institutional ownership reported to the SEC as of Q2 2025, from Form 13F filings. Source: https://holderbook.com/stocks/HLVX/

- Reporting holders: 74
- Reported value: $82.6M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Frazier Life Sciences Management, L.P.](https://holderbook.com/funds/1892134-frazier-life-sciences-management-l-p/) | $21.1M | 10,617,062 | 0.8% | 13 |
| [TAKEDA PHARMACEUTICAL CO LTD](https://holderbook.com/funds/1395064-takeda-pharmaceutical-co-ltd/) | $13.4M | 6,724,000 | 68.4% | 7 |
| [TANG CAPITAL MANAGEMENT LLC](https://holderbook.com/funds/1232621-tang-capital-management-llc/) | $9.8M | 4,920,000 | 0.5% | 4 |
| [EcoR1 Capital, LLC](https://holderbook.com/funds/1587114-ecor1-capital-llc/) | $4.8M | 2,420,243 | 0.3% | 1 |
| [LIGHTSPEED MANAGEMENT COMPANY, L.L.C.](https://holderbook.com/funds/1702122-lightspeed-management-company-l-l-c/) | $4.6M | 2,303,871 | 1.9% | 3 |
| [FRANKLIN RESOURCES INC](https://holderbook.com/funds/38777-franklin-resources-inc/) | $3.9M | 1,953,642 | 0.0% | 13 |
| [DEERFIELD MANAGEMENT COMPANY, L.P.](https://holderbook.com/funds/1009258-deerfield-management-company-l-p/) | $3.7M | 1,882,654 | 0.1% | 13 |
| [Carlyle Group Inc.](https://holderbook.com/funds/1527166-carlyle-group-inc/) | $3.6M | 1,838,486 | 0.1% | 10 |
| [VANGUARD GROUP INC](https://holderbook.com/funds/102909-vanguard-group-inc/) | $2.9M | 1,451,205 | 0.0% | 13 |
| [Balyasny Asset Management L.P.](https://holderbook.com/funds/1218710-balyasny-asset-management-l-p/) | $1.9M | 976,297 | 0.0% | 4 |
| [StepStone Group LP](https://holderbook.com/funds/1502287-stepstone-group-lp/) | $1.6M | 826,569 | 3.3% | 13 |
| [GOLDMAN SACHS GROUP INC](https://holderbook.com/funds/886982-goldman-sachs-group-inc/) | $916.4K | 460,505 | 0.0% | 5 |
| [SAMSARA BIOCAPITAL, LLC](https://holderbook.com/funds/1744967-samsara-biocapital-llc/) | $795.3K | 399,637 | 0.2% | 13 |
| [Trium Capital LLP](https://holderbook.com/funds/1963860-trium-capital-llp/) | $786.4K | 395,188 | 0.2% | 2 |
| [BlackRock, Inc.](https://holderbook.com/funds/2012383-blackrock-inc/) | $771.2K | 387,533 | 0.0% | 4 |
| [QIMING U.S. VENTURES MANAGEMENT, LLC](https://holderbook.com/funds/1909617-qiming-u-s-ventures-management-llc/) | $741.5K | 372,615 | 3.1% | 13 |
| [DEUTSCHE BANK AG\](https://holderbook.com/funds/948046-deutsche-bank-ag/) | $625.8K | 314,468 | 0.0% | 13 |
| [ACADIAN ASSET MANAGEMENT LLC](https://holderbook.com/funds/916542-acadian-asset-management-llc/) | $611.0K | 308,595 | 0.0% | 4 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $508.2K | 255,254 | 0.0% | 13 |
| [Stonepine Capital Management, LLC](https://holderbook.com/funds/1440771-stonepine-capital-management-llc/) | $449.8K | 226,009 | 0.4% | 3 |
| [TWO SIGMA ADVISERS, LP](https://holderbook.com/funds/1478735-two-sigma-advisers-lp/) | $421.1K | 211,600 | 0.0% | 5 |
| [RBF Capital, LLC](https://holderbook.com/funds/1134621-rbf-capital-llc/) | $398.0K | 200,000 | 0.0% | 1 |
| [MILLENNIUM MANAGEMENT LLC](https://holderbook.com/funds/1273087-millennium-management-llc/) | $350.9K | 176,327 | 0.0% | 6 |
| [MORGAN STANLEY](https://holderbook.com/funds/895421-morgan-stanley/) | $348.1K | 174,906 | 0.0% | 13 |
| [TWO SIGMA INVESTMENTS, LP](https://holderbook.com/funds/1179392-two-sigma-investments-lp/) | $338.7K | 170,209 | 0.0% | 7 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2025 | 74 | $82.6M |
| Q1 2025 | 80 | $61.1M |
| Q4 2024 | 76 | $88.7M |
| Q3 2024 | 79 | $73.5M |
| Q2 2024 | 93 | $658.8M |
| Q1 2024 | 80 | $732.9M |
| Q4 2023 | 69 | $685.9M |
| Q3 2023 | 68 | $459.3M |
| Q2 2023 | 54 | $436.6M |
| Q1 2023 | 61 | $436.4M |
| Q4 2022 | 55 | $440.2M |
| Q3 2022 | 50 | $399.9M |